Prosecution Insights
Last updated: November 04, 2026

Trace-Ability, Inc.

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Trace-Ability, Inc. maintains a patent portfolio in the Biotechnology & Pharmaceuticals technology area. There is currently 1 pending office action for the company. This 1 pending office action is being processed by 1 distinct examiner within 1 distinct art unit, reflecting a prosecution environment where all current activity is focused on a single application. For a practitioner, this means that the immediate success of the portfolio is tied to the outcome of this 1 pending office action.

The busiest examiner assigned to the portfolio is GREENE, CAROLYN LEE. She is responsible for 1 busiest examiner pending office action. This matches the total 1 pending office action for the entire company, meaning that all active examination for the portfolio is currently being handled by GREENE, CAROLYN LEE. The presence of 1 distinct art unit indicates that the technical focus of the current prosecution is limited to a specific area of biotechnology. Legal strategy should be tailored to the specific examination patterns of the 1 distinct examiner to move this pending action toward allowance.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
0
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 only1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
GREENE, CAROLYN LEE 1 65.4% +46.5%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18395034 VIABLE CELL DETECTION AND PROTOCOL IMPLEMENTING THE SAME GREENE, CAROLYN LEE 28d

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18395034 VIABLE CELL DETECTION AND PROTOCOL IMPLEMENTING THE SAME GREENE, CAROLYN LEE 28d

Top Art Units

Art UnitApps
1681 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18395034 VIABLE CELL DETECTION AND PROTOCOL IMPLEMENTING THE SAME GREENE, CAROLYN LEE 1681 §101 Final Rejection 28d Pending Dec 22, 2023

Managing Trace-Ability, Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Trace-Ability, Inc. have?

Trace-Ability, Inc. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Trace-Ability, Inc. applications?

Carolyn Lee Greene has the most, with 1 of Trace-Ability, Inc.'s pending office actions.

What technology area are Trace-Ability, Inc.'s patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month